Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × ruxolitinib × Clear all

Sponsor

Conditions

Primary Myelofibrosis 15 Myeloproliferative Disorders 13 Polycythemia Vera 8 Breast Neoplasms 6 Leukemia, Myeloid, Acute 5 Leukemia 5 Pancreatic Neoplasms 4 Multiple Myeloma 4 Hematologic Diseases 4 Myelodysplastic Syndromes 3 Bone Marrow Diseases 3 Thrombocytosis 2 Thrombocythemia, Essential 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Follicular 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Graft vs Host Disease 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia-Lymphoma, Adult T-Cell 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡